# Comparative effectiveness of ustekinumab vs. vedolizumab for anti-TNF-naïve or anti-TNF-exposed Crohn's disease: a multicenter cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-effectiveness-of-ustekinumab-vs-vedolizumab-for-anti-tnf-naive-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hongsheng Yang,Zhaopeng Huang,Miao Li,Haiyan Zhang,Lingyu Fu,Xiaoling Wang,Qiaoqiao Yang,Yun He,Wenhong Wu,Taofeng Jiang,Zhimei Sun,Tao Zhang,Dongping Lai,Xixin Wu,Lishuo Shi,Qin Guo,Yanhui Wu,Jian Tang,Kang Chao,Xiang Gao |
| Citations | 45 |
| DOI | 10.1016/j.eclinm.2023.102337 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.thelancet.com/article/S258953702300514X/pdf |
| OpenAlex ID | https://openalex.org/W4389266180 |
| PMID | 38089859 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Jian Tang](https://scholariq.org/researchers/jian-tang/)

## Paper journal

- [EClinicalMedicine](https://scholariq.org/journals/eclinicalmedicine/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.